Register to receive a free Interventional Cardiology Devices Market Report Suite for Europe 2018-2024 synopsis and brochure

The European interventional cardiology market is currently valued at nearly $1.4 billion. This is a mature market that has been in decline for many years as a result of market-wide factors, such as lack of innovation, consistent price erosion and increased competition. In recent years, the interventional cardiology market has been experiencing a period of consolidation, whereby large competitors are entering new market segments organically or through strategic mergers and acquisitions. This has resulted in tremendous downward pricing pressure, as consolidated companies have more power to bundle various devices at a discount in order to win tenders and contract offers with hospitals and labs.

Recent Mergers and Acquisition in Interventional Cardiology

A closer analysis of recent market transactions reveals that deals are, on average, becoming increasingly large in size. This trend is not unique to interventional cardiology markets and is prevalent in other mature medical device markets as well. Market segments that are smaller in size — like vascular closure devices, optical coherenace tomography (OCT) catheters and fractional flow reserve (FFR) guidewires — will be affected the most by recent market transactions. Recent cardiology mergers include:

Philips Acquires Spectranetics, Expanding its Image-guided Therapy Device Offerings

Abbott Completes Acquisition of St. Jude Medical

Teleflex to Acquire Vascular Solutions

Philips Acquires Volcano for $1 Billion to Expand Position in Interventional Lab Market

VCD Market Has the Greatest Downside

The vascular closure devices (VCD) market segment is expected to be amongst the most negatively affected in the market, as the anticipated price erosion will outpace growth in sales volume. In addition…

This article was originally published on DAIC, to read more please visit https://www.dicardiology.com/article/recent-acquisitions-eroding-prices-billion-dollar-european-interventional-cardiology-market

For Further Market Information 
More can be found in a series of reports published by iData Research entitled the Europe Market Report Suite for Interventional Cardiology Devices 2018. This research includes coronary stents, coronary balloon catheters, interventional coronary catheters and guidewires, introducer sheaths, coronary embolic protection devices, coronary atherectomy devices, coronary vascular closure devices, diagnostic coronary catheters and guidewires, coronary intravascular ultrasound (IVUS) catheters and coronary optical coherence tomography (OCT) catheters.

iData’s suite of reports on this subject covers the United States, Japan, and 15 countries in Europe. These include a comprehensive analysis on units sold, market values, average selling prices, forecasts, procedure data, as well as detailed competitive market shares and analysis of all major players. In addition, the research includes product assessments, product pipelines, recalls as well as SWOT analyses.

Email us at [email protected] or register online for an Europe Market Report Suite for Interventional Cardiology Devices 2018 brochure and free sample.

About iData Research
iData Research (www.idataresearch.com) is an international consulting and market research firm, dedicated to providing the best in market intelligence for the medical device industry. Their research empowers their clients by providing them with the necessary tools to achieve their goals and do it right the first time.